Bioregenx (BRGX) Liabilities and Shareholders Equity (2021 - 2026)
Bioregenx (BRGX) posted Liabilities and Shareholders Equity of $337070.0 for Q1 2026, down 17.99% on a QoQ basis from $410986.0 in Q4 2025, and down 30.16% year-over-year from $482623.0 in Q1 2025.
Powered by 
Analysis
Bioregenx (BRGX) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends
Bioregenx has reported Liabilities and Shareholders Equity for 6 years, with the latest figure at $337070.0 in Q1 2026.
- On a quarterly basis, Liabilities and Shareholders Equity fell 30.16% year-over-year to $337070.0 in Q1 2026; TTM through Mar 2026 was $3.1 million, a 91.54% decrease from a year earlier, with the FY2025 full-year figure at $410986.0, down 19.18% from the prior year.
- Liabilities and Shareholders Equity was $337070.0 for Q1 2026 at Bioregenx, down from $410986.0 in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $18.6 million in Q1 2024, with the low at $33981.0 in Q3 2023.
- Average Liabilities and Shareholders Equity over 5 years is $4.2 million, with a median of $495579.0 recorded in 2024.
- The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity soared 50991.39% in 2024, then tumbled 97.41% in 2025.
- Over 5 years, Liabilities and Shareholders Equity stood at $59149.0 in 2022, then surged by 1363.68% to $865750.0 in 2023, then plunged by 41.26% to $508535.0 in 2024, then fell by 19.18% to $410986.0 in 2025, then slipped by 17.99% to $337070.0 in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $337070.0 (Q1 2026), $410986.0 (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | 20.88 Bn |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | 93.31 Bn |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | 47.93 Bn |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | 13.87 Bn |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | 6.46 Bn |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | 8.97 Bn |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | 31.10 Bn |
| 10 | Bioregenx | 9.72 Mn | 9.67 Mn | 348,288.00 | 337,070.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 337,070.00 |
| Dec 31, 2025 | 410,986.00 |
| Sep 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 1.15 Mn |
| Mar 31, 2025 | 482,623.00 |
| Dec 31, 2024 | 508,535.00 |
| Sep 30, 2024 | 17.36 Mn |
| Jun 30, 2024 | 17.89 Mn |
| Mar 31, 2024 | 18.62 Mn |
| Dec 31, 2023 | 865,750.00 |
| Sep 30, 2023 | 33,981.00 |
| Jun 30, 2023 | 85,506.00 |
| Mar 31, 2023 | 77,989.00 |
| Dec 31, 2022 | 59,149.00 |
| Dec 31, 2021 | 127,762.00 |
API Access
Bioregenx Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=BRGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "BRGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=BRGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();